Xtx Topco LTD Avrobio, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.15 - $1.48 $35,183 - $45,279	-30,594 Reduced 55.67%	24,359 $31,000
Q4 2023 Feb 13, 2024	BUY	$1.22 - $1.62 $31,532 - $41,870	25,846 Added 88.8%	54,953 $74,000
Q3 2023 Nov 13, 2023	BUY	$0.98 - $1.62 $28,524 - $47,153	29,107 New	29,107 $44,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $17,466 - $30,974	-23,289 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.29 - $4.04 $172 - $541	134 Added 0.58%	23,289 $31,000
Q4 2021 Feb 11, 2022	BUY	$3.45 - $6.05 $79,884 - $140,087	23,155 New	23,155 $89,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.